Clinical trial
Study of an Approved Drug in Patients With Asthma (0476-289)(COMPLETED)
NCT00092144 · Organon and Co, Industry · Completed
Key facts
| NCT number | NCT00092144 |
|---|---|
| Title | Study of an Approved Drug in Patients With Asthma (0476-289)(COMPLETED) |
| Official title | A Multicenter, Double-Blind, Placebo-Controlled, Randomized, Parallel-Group Study to Evaluate the Clinical Effect of Oral MK0476 Vs Placebo During the Allergy Season in Patients With Seasonal Aeroallergen Sensitivity and Chronic Asthma Which is Also Active During Allergy Season |
| Lead sponsor | Organon and Co, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Asthma |
| Intervention type | Drug |
| Interventions | MK0476, montelukast sodium / Duration of Treatment: 4 weeks, Comparator: placebo / Duration of Treatment: 4 weeks |
| Enrollment | 500 |
| Start date | Feb 26, 2004 |
| Primary completion | Jun 15, 2004 |
| Completion | Jun 15, 2004 |
| First posted | Sep 24, 2004 |
| Last update posted | Aug 15, 2024 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: